THURSDAY 28Looking for Vulnerable Plaque7:20 AM New VH Findings: Plaque Stability andLesion RiskM Pauliina Margolis7:30 AM Plaque Profilings: Insights from the CulpritPlaquesCheol Whan Lee7:40 AM Panel Discussion and Q & A8:10 AM AdjournNew DES TechnologiesOrganized by CVRFRoom 4-1, Level 4Moderators: Mitchell W. Krucoff, Barry D. RutherfordPanelists: Dominic Allocc, Jilin Chen, Rajeev Edakutty,Dong Woon Jeon, Gaku Nakazawa, Yuji Oikawa,Abdullah M.A Shehab7:00 AM Assessment of New Stent Designs: Can WeBalance Ongoing Innovation & Safety Evaluation?Mitchell W. Krucoff7:10 AM EPC Capture Stent Program for STEMIHarry Suryapranata7:20 AM Traditional and Novel Metal Alloys:Advantages, Disadvantages and TrendsJuan Granada7:30 AM Can Biodegradable Polymer DES Be Betterthan 2nd Generation DES?Gaku Nakazawa7:40 AM Panel Discussion and Q & A8:10 AM AdjournDrug-coated Stent or Balloon for PVD"New Horizon for PVD"Organized by CVRFRoom 4-2, Level 4Moderators: John R. Laird, Jr., Andrej SchmidtPanelists: Taehoon Ahn, Motoharu Araki, Mark W. Burket,Gim Hooi Choo, Debabrata Dash, Richard R. Heuser,Chung-Ho Hsu, Naoto Inoue, Upendra Kaul,Issam D. Moussa, Sreenivas Reddy.S., Manish Taneja7:00 AM The Promise of Tibial Drug-Coated BalloonsAndrej Schmidt7:12 AM Will Drug-coated Balloons, Drug-coatedStents Shift the Paradigm for Femoropopliteal LesionMark W. Burket7:24 AM Panel Discussion and Q & A8:10 AM AdjournLunchtime Activities12:45 PM-1:45 PMEverolimus Powered by PlatinumChromium: First One-Year Clinical DataReleaseOrganized by CVRF and Supported by Educational Grantfrom Boston Scientific KoreaCoronary Arena, Level 1Moderators: Antonio Colombo, Ki Bae SeungPanelists: Young-Keun Ahn, Dominic Allocco,Kook-Jin Chun, Jae Ung Lee12:45 PM Wel<strong>com</strong>e AddressAntonio Colombo12:50 PM PLATINUM Workhorse Data from ACCGregg W. Stone1:10 PM Real World Experience of Promus ElementStentHuay Cheem Tan1:25 PM Case PresentationJae Ung Lee1:35 PM Case PresentationJin Bae Lee1:45 PM Discussion1:50 PM Closing RemarkKi Bae SeungNobori: The Next Generation DES ClinicalUpdates and Use in PracticeOrganized by CVRF and Supported by Educational Grantfrom Terumo Korea CorporationEndovascular Arena, Level 1Moderators: Takeshi Kimura, Seung-Jung Park12:45 PM Opening WordsTakeshi Kimura12:50 PM NOBORI Clinical ProgramBernard Chevalier1:05 PM NOBORI 2Gian Battista Danzi1:20 PM The Use of Nobori in BifurcationYoung-Hak Kim1:35 PM Discussion1:45 PM Closing & Take Home MessageSeung-Jung ParkThe Drug Eluting Stent in the SFA-ZilverPTXOrganized by CVRF and Supported by Educational Grantfrom Cook Medical KoreaRoom 1-1, Level 1Moderator: Donghoon ChoiPanelists: Mark W. Burket, Bryan Ping-Yen Yan12:45 PM Wel<strong>com</strong>e AddressDonghoon Choi12:50 PM The Drug Eluting Stent in the SFAMark W. Burket1:10 PM The Real World Data & Experience of Zilver-PTXBryan Ping-Yen Yan1:30 PM Q & A and Panel Discussion1:45 PM AdjournDonghoon ChoiFrom a DES to a BMS-BiodegradablePolymer Technology: Designed toImprove Long Term Patient Out<strong>com</strong>es!Organized by CVRF and Supported by Educational Grantfrom DIO Corp. / BiosensorsRoom 2-1, Level 2Moderators: Eberhard Grube, Myung-Ho JeongPanelists: Jang-Ho Bae, Kiyuk Chang, Seung-Ho Hur,Ng Kok Huan, Seung-Hwan Lee,Rogelio Ventura Tangco, Cheol Woong Yu12:45 PM OpeningMyung-Ho Jeong12:50 PM Evidence Based Medicine: DoesBioMatrix TM Bring Patent Benefit? - 3 Yr/SubgroupFollow Up from LEADERS TrialEberhard Grube1:05 PM Evaluation of Effectiveness and Safety ofBioMatrix TM - Biolimus A9 TM stEnt in patients with AcUTecoronary sYndromeYoung Joon Hong1:15 PM BioMatrix TM : The Next GenerationBiodegradable Polymer Technology - KoreanExperienceKyung Woo Park50
1:25 PM A Single Center Clinical Experience UsingBiolimus-Eluting Stent with Biodegradable PolymerIl Rhee1:35 PM Panel Discussion1:45 PM AdjournImproving the Management & FutureDirection for HypertensionOrganized by CVRF and Supported by Educational Grantfrom NovartisRoom 3-1, Level 3Moderators: Shung Chull Chae, Byung-Hee Oh12:45 PM Improving Effect of ARB to AsianHypertension PatientsJeong Bae Park1:00 PM Rationale for the Use of Single PillCombination and Asian Data of ARB/CCB SPCSeungwoo Park1:15 PM How Can We Move beyond ACEIs andARBs to Improve Cardio-renal Protection?Kwang Il Kim1:30 PM Discussion1:45 PM AdjournWhat Is the Optimal Procedure forBelow-The-Knee?Organized by CVRF and Supported by Educational Grantfrom Johnson & Johnson Medical KoreaTutorial Arena, Level 4Moderators: Taehoon Ahn, Seung-Woon RhaPanelists: Osamu Iida, Young-Guk Ko, Jae-Hwan Lee,Andrej Schmidt, Kazushi Urasawa12:45 PM ACHILLES Study (DES for BTK)Andrej Schmidt1:00 PM Tibial CTO ManagementKazushi Urasawa1:15 PM Optimal Treatment for Below-the-kneeYoung-Guk Ko1:30 PM Q & ASeung-Woon Rha1:45 PM AdjournTailor Made Anti-thrombic Therapy afterPCI Based on Current EvidenceOrganized by CVRF and Supported by Educational Grantfrom Korea Otsuka Pharmaceutical Co., Ltd./Korea OIAACo., Ltd.Room 4-1, Level 4Moderators: Junbo Ge, Seong-Wook Park12:45 PM Cilostazol as a Solution for Patients withGenetic Risk of Antiplatelet Therapy Resistance:Insights from the CILON-T TrialKyung Woo Park1:10 PM Tailored Approach to Reduction ofRestenosis after DES Implantation: Results fromPooled Analysis of DECLARE TrialsSeung-Whan Lee1:35 PM DiscussionJunbo Ge, Seong-Wook Park1:45 PM AdjournEvening Symposium6:15 PM-9:00 PMExpand the Realm of Statin TreatmentOrganized by CVRF and Supported by EducationalGrant from Pfizer Pharmaceutical Korea Ltd.Room 1-1, Level 1Moderator: Joo-Young YangPanelists: In-Ho Chae, Weon Kim, Han Cheol Lee6:15 PM Dinner7:00 PM The Effects of Pre-procedural StatinTreatment before PCI and CABGHan Cheol Lee8:00 PM Panel Discussion and Q & A8:30 PM AdjournStructural Heart Disease SymposiumOrganized by CVRF and Supported by EducationalGrant from AGA CorporationEndovascular Arena, Level 1Moderators: I-Seok Kang, Horst SievertPanelists: Mazeni Alwi, Eun-Jung Bae, MohammedOmar Galal, Hong Gu, Myung Chul Hyun, HyoungDoo Lee, Li Fen6:15 PM Dinner7:00 PM Stent Therapy for BT Shunt Obstruction in SVElsa Suh7:12 PM CoA StentingFrank Ing7:24 PM Transcatheter Closure of Large ASDs inSmall Children: Acute Results and Short Term Follow UpBharat Dalvi7:36 PM Catheter Closure of Multiple ASDsTeiji Akagi7:48 PM Technical Aspects of Device Closure of ASDwith Special Reference to Avoidance of ComplicationsR. Krishna Kumar8:00 PM Innovations and Improvisations in the CathLabR. Krishna Kumar8:12 PM Closing the Ductus in the Presence ofPulmonary HypertensionSeong-Ho Kim8:24 PM Using PDA Device for Multi IndicationsLan Hieu Nguyen8:36 PM Panel Discussion9:00 PM Adjourn51